Literature DB >> 21233082

Purpura fulminans: recognition, diagnosis and management.

E Chalmers1, P Cooper, K Forman, C Grimley, K Khair, A Minford, M Morgan, A D Mumford.   

Abstract

Purpura fulminans (PF) is a haematological emergency in which there is skin necrosis and disseminated intravascular coagulation. This may progress rapidly to multi-organ failure caused by thrombotic occlusion of small and medium-sized blood vessels. PF may complicate severe sepsis or may occur as an autoimmune response to otherwise benign childhood infections. PF may also be the presenting symptom of severe heritable deficiency of the natural anticoagulants protein C or protein S. Early recognition and treatment of PF is essential to reduce mortality and to prevent major long-term health sequelae. However, management strategies require accurate identification of the underlying cause. This review focuses on the clinical features, differential diagnosis and laboratory features of the range of PF disorders and includes expert consensus opinion about immediate and on-going management.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233082     DOI: 10.1136/adc.2010.199919

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  35 in total

1.  Delayed Surgical Debridement and Use of Semiocclusive Dressings for Salvage of Fingers After Purpura Fulminans.

Authors:  Paula A Pino; Javier A Román; Felipe Fernández
Journal:  Hand (N Y)       Date:  2016-08-03

2.  Purpura fulminans caused by meningococcemia in an infant.

Authors:  Asad Abbas; Athar Abdul Mujeeb
Journal:  BMJ Case Rep       Date:  2013-08-06

Review 3.  Activated protein C: biased for translation.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

Review 4.  Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring.

Authors:  Meilang Xue; Christopher J Jackson
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

Review 5.  Protein C anticoagulant and cytoprotective pathways.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

6.  Four-extremity amputation following disseminated intravascular coagulation and purpura fulminans.

Authors:  Umar F Bhatti; Aaron M Williams; Krishnan Raghavendran; Patrick E Georgoff
Journal:  BMJ Case Rep       Date:  2019-03-20

7.  [Sepsis-associated Purpura Fulminans International Registry--Europe (SAPFIRE)].

Authors:  F M Brunkhorst; V Patchev
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-10-29       Impact factor: 0.840

8.  Infectious purpura fulminans.

Authors:  J Harikrishna; Alladi Mohan
Journal:  Indian J Med Res       Date:  2015-01       Impact factor: 2.375

9.  Antibody SPC-54 provides acute in vivo blockage of the murine protein C system.

Authors:  Laurent Burnier; José A Fernández; John H Griffin
Journal:  Blood Cells Mol Dis       Date:  2013-02-04       Impact factor: 3.039

10.  Sepsis-induced purpura fulminans caused by Pasteurella multocida.

Authors:  Lisa Borges; Nelson Oliveira; Isabel Cássio; Humberto Costa
Journal:  BMJ Case Rep       Date:  2014-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.